Cochrane Abstracts
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mammographic Density, Endocrine Therapy and Breast Cancer Risk: a Prognostic and Predictive Biomarker Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436464/all/Mammographic_density__endocrine_therapy_and_breast_cancer_risk:_a_prognostic_and_predictive_biomarker_review.
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436464/all/Mammographic_density__endocrine_therapy_and_breast_cancer_risk:_a_prognostic_and_predictive_biomarker_review. Accessed February 7, 2026.
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436464/all/Mammographic_density__endocrine_therapy_and_breast_cancer_risk:_a_prognostic_and_predictive_biomarker_review
Mammographic Density, Endocrine Therapy and Breast Cancer Risk: a Prognostic and Predictive Biomarker Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436464/all/Mammographic_density__endocrine_therapy_and_breast_cancer_risk:_a_prognostic_and_predictive_biomarker_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review
ID - 436464
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436464/all/Mammographic_density__endocrine_therapy_and_breast_cancer_risk:_a_prognostic_and_predictive_biomarker_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
